Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This randomized controlled trial will evaluate the effect of intravitreal faricimab or fluocinolone acetonide (FAc) intravitreal implant compared with observation on long-term visual acuity following treatment of choroidal melanoma with iodine-125 plaque brachytherapy.
Epistemonikos ID: d71d4725774d63da5a9da6e3a6dfc3f3584b87c5
First added on: Feb 19, 2024